Abstract:Colorectal cancer (CRC) is the third most prevalent and second most lethal cancer globally, with gene mutations and tumor metastasis contributing to its poor prognosis. Single-cell sequencing technology enables high-throughput analysis of the genome, transcriptome, and epigenetic landscapes at the single-cell level. It offers significant insights into analyzing the tumor immune microenvironment, detecting tumor heterogeneity, exploring metastasis mechanisms, and monitoring circulating tumor cells (CTCs). This article provides a brief overview of the technical procedure and data processing involved in single-cell sequencing. It also reviews the current applications of single-cell sequencing in CRC research, aiming to enhance the understanding of intratumoral heterogeneity, CRC development, CTCs, and novel drug targets. By exploring the diverse molecular and clinicopathological characteristics of tumor heterogeneity using single-cell sequencing, valuable insights can be gained into early diagnosis, therapy, and prognosis of CRC. Thus, this review serves as a valuable resource for identifying prognostic markers, discovering new therapeutic targets, and advancing personalized therapy in CRC.

What problem does this paper attempt to address?

This paper mainly discusses the application of single-cell sequencing technology in the study of colorectal cancer (CRC). CRC is the third most common and second deadliest cancer globally, with genetic mutations and tumor metastasis leading to poor prognosis. Traditional large-scale sequencing methods cannot reveal the heterogeneity between cells within tissues. However, single-cell sequencing technology can analyze the genome, transcriptome, and epigenetic landscape of individual cells in a high-throughput manner, thus allowing for in-depth analysis of the tumor microenvironment, detection of tumor heterogeneity, exploration of metastasis mechanisms, and monitoring of circulating tumor cells (CTCs). The paper outlines the technical workflow and data processing of single-cell sequencing, and reviews the latest applications of this technology in CRC research, with the aim of enhancing our understanding of tumor heterogeneity, CRC development, CTCs, and new drug targets. Through single-cell sequencing, diverse molecular and clinical pathological characteristics of tumor heterogeneity can be explored, providing valuable insights for the early diagnosis, treatment, and prognosis of CRC. Therefore, this review is of great significance for identifying prognostic markers, discovering new therapeutic targets, and advancing personalized treatment for CRC.

Application of Single-Cell Sequencing Technology in Research on Colorectal Cancer